美国 · 股市与财经 · Investor's Business Daily

Teva, Already Up 26% This Year, Surges Again On First-Of-Its-Kind Approval

来源：Investor's Business Daily · 美国 23 小时前

Teva stock surged Friday after the FDA approved its schizophrenia drug, a once-monthly injectable treatment for the disease.

在 Investor's Business Daily 阅读全文登录后可收藏

MediaNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.investors.com)

推荐阅读

Business Insider

I avoided shopping on Amazon for 449 days. Having a baby brought me back to it, but I'm shopping smarter now.

Artificial Intelligence Stocks Under $10

From tax to slack: this World Mental Health Day, reclaim cognitive space in the era of machine speed

The states with the most primary care doctors per capita

Tech chief says EU can fend off rogue AI risk: Report

Bitcoin's volatility has plunged, but extreme price swings are more frequent than in 2018